Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

Percent body fat and bone mineral density were measured by dual x-ray absorptiometry.

Indirect calorimetry was used to determine REE and to calculate respiratory quotients.

Why It Was Studied

Obesity and hypotonia in children with Prader-Willi syndrome (PWS) are accompanied by abnormal body composition and diminished energy expenditure resembling a growth hormone deficient state.

Who Took Part

The abstract describes 54 children taking part.

The age groups tagged for this paper are children, both men and women.

How the Study Was Run

The researchers set it up as a randomized study.

The children were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

What Was Measured

PubMed files the paper under topics including Adipose Tissue, Body Composition, Bone Density, Carbohydrate Metabolism, Energy Metabolism, Growth and Human Growth Hormone.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 54 children.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 1999 (The Journal of pediatrics), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.